SEC Form 4 · accession 0001179110-18-009761
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Young Kwon
Officer — SVP, Corporate Development
Period of report
Jul 13, 2018
Accepted (ET)
Jul 17, 2018 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 13, 2018 | M | 11,000 | $13.26 | A | 136,624 | D | |
| Common StockF2 | Jul 13, 2018 | S | 11,000 | $27.40 | D | 125,624 | D | |
| Common Stock | Jul 13, 2018 | M | 8,000 | $15.44 | A | 133,624 | D | |
| Common StockF2 | Jul 13, 2018 | S | 8,000 | $27.40 | D | 125,624 | D | |
| Common Stock | Jul 13, 2018 | M | 6,000 | $12.58 | A | 131,624 | D | |
| Common StockF2 | Jul 13, 2018 | S | 6,000 | $27.40 | D | 125,624 | D | |
| Common Stock | Jul 13, 2018 | M | 6,000 | $17.96 | A | 131,624 | D | |
| Common StockF2 | Jul 13, 2018 | S | 6,000 | $27.48 | D | 125,624 | D | |
| Common Stock | Jul 13, 2018 | M | 3,500 | $13.02 | A | 129,124 | D | |
| Common StockF2 | Jul 13, 2018 | S | 3,500 | $27.33 | D | 125,624 | D | |
| Common Stock | Jul 13, 2018 | M | 4,000 | $21.56 | A | 129,624 | D | |
| Common StockF2 | Jul 13, 2018 | S | 4,000 | $27.40 | D | 125,624 | D | |
| Common StockF2 | Jul 13, 2018 | S | 11,000 | $27.35 | D | 114,624 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option(Right to Buy) | $13.26 | Jul 13, 2018 | M | 11,000 | D | Feb 22, 2015 | Feb 22, 2021 | Common Stock | 11,000 | 19,500 | D |
| Stock Option(Right to Buy) | $15.44 | Jul 13, 2018 | M | 8,000 | D | Feb 14, 2016 | Feb 14, 2022 | Common Stock | 8,000 | 8,500 | D |
| Stock Option(Right to Buy) | $12.58 | Jul 13, 2018 | M | 6,000 | D | Feb 19, 2017 | Feb 19, 2023 | Common Stock | 6,000 | 10,800 | D |
| Stock Option(Right to Buy) | $17.96 | Jul 13, 2018 | M | 6,000 | D | Feb 18, 2018 | Feb 18, 2024 | Common Stock | 6,000 | 13,986 | D |
| Stock Option(Right to Buy) | $13.02 | Jul 13, 2018 | M | 3,500 | D | May 18, 2018 | Feb 18, 2025 | Common Stock | 3,500 | 22,225 | D |
| Stock Option(Right to Buy) | $21.56 | Jul 13, 2018 | M | 4,000 | D | May 11, 2018 | Aug 11, 2025 | Common Stock | 4,000 | 14,000 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F2This transaction was executed in multiple trades at prices ranging from $26.90 to $27.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.